Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. Aurisco Pharmaceutical Co.,Ltd.
  6. News
  7. Summary
    605116   CNE1000042S4

AURISCO PHARMACEUTICAL CO.,LTD.

(605116)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Aurisco Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020

04/19/2021 | 09:45am EST

Aurisco Pharmaceutical Co.,Ltd. announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was CNY 721.440 million compared to CNY 581.632 million a year ago. Operating income was CNY 187.270 million compared to CNY 170.710 million a year ago. Net income was CNY 157.227 million compared to CNY 186.130 million a year ago. Basic earnings per share from continuing operations was CNY 0.42 compared to CNY 0.52 a year ago.


ę S&P Capital IQ 2021
All news about AURISCO PHARMACEUTICAL CO.,LTD.
2021Aurisco Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended Sept..
CI
2021Certain A Shares of Aurisco Pharmaceutical Co.,Ltd. are subject to a Lock-Up Agreement ..
CI
2021AURISCO PHARMACEUTICAL CO.,LTD.(SHSE : 605116) added to Shanghai Stock Exchange A Share In..
CI
2021AURISCO PHARMACEUTICAL CO.,LTD.(SHSE : 605116) added to Shanghai Stock Exchange Composite ..
CI
2021Aurisco Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 3..
CI
2021Aurisco Pharmaceutical Co.,Ltd. Announces Earnings Results for the First Quarter Ended ..
CI
2021Aurisco Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended Decemb..
CI
2020Yangzhou Aurisco Pharmaceutical Co., Ltd. announced that it expects to receive CNY 200 ..
CI
2020Aurisco Pharmaceutical Co.,Ltd. Announces Major Financial Indicators in 1St Three Quart..
CI
2020Aurisco Pharmaceutical Co.,Ltd. has completed an IPO in the amount of CNY 343.17 millio..
CI
More news
Financials
Sales 2021 819 M 129 M 129 M
Net income 2021 185 M 29,2 M 29,2 M
Net Debt 2021 - - -
P/E ratio 2021 44,6x
Yield 2021 -
Capitalization 8 092 M 1 277 M 1 279 M
Capi. / Sales 2021 9,88x
Capi. / Sales 2022 8,97x
Nbr of Employees 939
Free-Float -
Chart AURISCO PHARMACEUTICAL CO.,LTD.
Duration : Period :
Aurisco Pharmaceutical Co.,Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 1
Last Close Price 20,50 
Average target price
Spread / Average Target -
EPS Revisions
Managers and Directors
Ding Jun Chu Chief Executive Officer & Director
Xiu Yu Wang Chief Financial Officer
Zhi An Peng Chairman
Ping Jin Chairman-Supervisory Board
De Fa Zhang Chief Engineer & Production Manager
Sector and Competitors
1st jan.Capi. (M$)
AURISCO PHARMACEUTICAL CO.,LTD.-6.90%1 297
JOHNSON & JOHNSON-3.62%434 036
ROCHE HOLDING AG-4.87%319 830
PFIZER, INC.-10.60%296 303
ABBVIE INC.-2.53%233 325
ELI LILLY AND COMPANY-12.00%220 356